- Home
- Johnson & Johnson
Johnson & Johnson
2 pandemics, 1 goal: Meet 4 innovators with high-tech ideas for fighting tuberculosis in the time of COVID-19
Despite being preventable and curable, tuberculosis is one of the world’s deadliest infectious diseases—and COVID-19 is making it even harder to diagnose and treat it. Enter these healthcare visionaries, who’ve made it their mission to move the world closer to the goal of ending tuberculosis.
One year later: The head of Johnson & Johnson China looks back on what we’ve learned from the pandemic—and how it can help shape the future
Will Song’s teams were on the front lines when COVID-19 shut down the city of Wuhan. One year to the day that the World Health Organization declared the disease a pandemic, he shares how the company kept going during the crisis and the innovative ideas that emerged from it.
Johnson & Johnson Chairman and CEO appears at the White House to discuss the company’s collaboration with Merck and future vaccine production
Learn more about the event, Johnson & Johnson’s historic collaboration with Merck—and watch a video that chronicles the progress that the company has made since last March in the fight against COVID-19.
6 trailblazing Johnson & Johnson scientists, past and present
For Women’s History Month, we’re spotlighting three of the company’s pioneering early female scientists—and their modern-day counterparts, who are not only innovating in the lab, but also paving the way for the next generation of powerhouse women.
4 things we now know about the rare disease AL amyloidosis
Imagine having a disease that many doctors have never seen before. That’s what Marty Verel experienced when he was told he had AL amyloidosis—and it’s what hematologist Brendan Weiss, M.D., is determined to help change. For Rare Disease Day, Dr. Weiss shares what he’s learned studying the rare disease.
A message from Chairman and CEO Alex Gorsky about the Emergency Use Authorization of Johnson & Johnson’s Janssen COVID-19 vaccine
The company leader shares the latest news about the U.S. Food and Drug Administration’s decision about the single-shot Janssen COVID-19 vaccine.
“COVID-19 inspired me to improve patient care": How two nurses devised new ways to help kids and fellow nurses during the pandemic
From a virtual reality game that helps children with remote physical therapy to a clever way to upgrade personal protective equipment for healthcare workers, the winning ideas from the latest Johnson & Johnson Nurses Innovate QuickFire Challenge came out of medical conundrums posed by the pandemic. Meet the women behind them.
4 ways Johnson & Johnson has worked to make access to medicines around the world more equitable
The Access to Medicine Index, a ranking of pharmaceutical companies’ work to distribute medications to low- and middle-income countries, just named Johnson & Johnson #3 on its biennial list, underscoring the company’s deep history of ensuring people in underserved communities receive the treatments they need.
What you need to know about Johnson & Johnson’s 2020 fourth-quarter and full-year earnings report
Check out this infographic breakdown of the company’s fourth-quarter and annual performance, with highlights from its consumer, pharmaceutical and medical devices businesses.
“My heart and mind feel lighter": Meet a health worker who leaned on support from a unique psychological training program during the pandemic
Vusumuzi Christopher Mnqayi didn’t realize how much of a toll his job as a community health worker in South Africa was taking on his mental health. That is, until he received coaching that has transformed the way he copes with the challenges of his crucial front line role.